Pubblicazioni scientifiche

Cancella testo

Open Access

1062 pubblicazioni

Muratori P.; Granito A.; Pappas G.; Pendino G.M.; Quarneti C.; Cicola R.; Menichella R.; Ferri S.; Cassani F.; Bianchi F.B.; Lenzi M.; Muratori L., The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome., «THE AMERICAN JOURNAL OF GASTROENTEROLOGY», 2009, 104, pp. 1420 - 1425 [Articolo in rivista]
Muratori P.; Granito A.; Pappas G.; Muratori L., Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients., «HEPATOLOGY», 2009, 49, pp. 1782 - 1783 [Articolo in rivista]
Ferri S.; Muratori L.; Quarneti C.; Muratori P.; Menichella R.; Pappas G.; Granito A.; Ballardini G.; Bianchi F.B.; Lenzi M., Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C., «JOURNAL OF HEPATOLOGY», 2009, 50, pp. 1093 - 1101 [Articolo in rivista]
Muratori P.; Granito A.; Quarneti C.; Ferri S.; Menichella R.; Cassani F.; Pappas G.; Bianchi F.B.; Lenzi M.; Muratori L., Autoimmune hepatitis in Italy: the Bologna experience., «JOURNAL OF HEPATOLOGY», 2009, 50, pp. 1210 - 1218 [Articolo in rivista]
Muratori P.; Granito A.; Ferri S.; Pappas G.; Volta U.; Menichella R.; Bianchi F.B.; Lenzi M.; Muratori L., Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis., «AUTOIMMUNITY», 2009, 42, pp. 224 - 227 [Articolo in rivista]
Granito A.; Bolondi L., Medical Treatment of Hepatocellular Carcinoma, «MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES», 2009, 1, pp. 1 - 9 [Articolo in rivista]
Hughes T; Saglio G; Branford S; Soverini S; Kim DW; Müller MC; Martinelli G; Cortes J; Beppu L; Gottardi E; Kim D; Erben P; Shou Y; Haque A; Gallagher N; Radich J; Hochhaus A., Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase., «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27, pp. 4204 - 4210 [Articolo in rivista]
Palandri F; Testoni N; Luatti S; Marzocchi G; Baldazzi C; Stacchini M; Castagnetti F; Breccia M; Specchia G; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G., Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results., «LEUKEMIA & LYMPHOMA», 2009, 50(1), pp. 114 - 118 [Articolo in rivista]
Baccarani M; Rosti G; Castagnetti F; Haznedaroglu I; Porkka K; Abruzzese E; Alimena G; Ehrencrona H; Hjorth-Hansen H; Kairisto V; Levato L; Martinelli G; Nagler A; Nielsen JL; Ozbek U; Palandri F; Palmieri F; Pane F; Rege-Cambrin G; Russo D; Specchia G; Testoni N; Weiss-Bjerrum O; Saglio G; Simonsson B., Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of patients with high risk, Philadelphia-positive, chronic myeloid leukaemia: a European LeukemiaNet study, «BLOOD», 2009, 113(19), pp. 504 - 4497 [Articolo in rivista]
Palandri F; Ottaviani E; Salmi F; Catani L; Polverelli N; Fiacchini M; Martinelli G; Baccarani M; Vianelli N., JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients, «LEUKEMIA & LYMPHOMA», 2009, 50, pp. 247 - 253 [Articolo in rivista]
Castagnetti F; Palandri F; Amabile M; Testoni N; Luatti S; Soverini S; Iacobucci I; Breccia M; Rege Cambrin G; Stagno F; Specchia G; Galieni P; Iuliano F; Pane F; Saglio G; Alimena G; Martinelli G; Baccarani M; Rosti G., Results of high-dose imatinib mesylate in intermediate SOKAL risk chronic myeloid leukemia patients in early chronic phase: A phase II trial of the GIMEMA CML WP, «BLOOD», 2009, 113(15), pp. 3428 - 3434 [Articolo in rivista]
Palandri F; Iacobucci I; Soverini S; Castagnetti F; Poerio A; Testoni N; Alimena G; Breccia M; Rege-Cambrin G; Tiribelli M; Varaldo R; Abruzzese E; Martino B; Luciano L; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G., Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response, «CLINICAL CANCER RESEARCH», 2009, 15, pp. 1059 - 1063 [Articolo in rivista]
Soverini S; Gnani A; Colarossi S; Castagnetti F; Abruzzese E; Paolini S; Merante S; Orlandi E; de Matteis S; Gozzini A; Iacobucci I; Palandri F; Gugliotta G; Papayannidis C; Poerio A; Amabile M; Cilloni D; Rosti G; Baccarani M; Martinelli G., Philadelphia-positive patients who already harbour imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors., «BLOOD», 2009, 114, pp. 2168 - 2171 [Articolo in rivista]
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R., IKZF1 (Ikaros) Deletions in BCR-ABL1-Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report, «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27, pp. 5202 - 5207 [Articolo in rivista]
Papayannidis C; Derenzini E; Iacobucci I; Curti A; Paolini S; Cilloni D; Baccarani M; Martinelli G., Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia., «AMERICAN JOURNAL OF HEMATOLOGY», 2009, 84(12), pp. 849 - 850 [Articolo in rivista]
Iacobucci I; Storlazzi CT; Cilloni D; Lonetti A; Ottaviani E; Soverini S; Astolfi A; Chiaretti S; Vitale A; Messa F; Impera L; Baldazzi C; D'Addabbo P; Papayannidis C; Lonoce A; Colarossi S; Vignetti M; Piccaluga PP; Paolini S; Russo D; Pane F; Saglio G; Baccarani M; Foà R; Martinelli G., Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP), «BLOOD», 2009, 114, pp. 2159 - 2167 [Articolo in rivista]
Martinelli G; Iacobucci I; Papayannidis C; Soverini S., New targets for Ph+ leukaemia therapy., «BAILLIERE'S BEST PRACTICE IN CLINICAL HAEMATOLOGY», 2009, 22, pp. 445 - 454 [Articolo in rivista]
Palandri F; Castagnetti F; Soverini S; Poerio A; Gugliotta G; Luatti S; Amabile M; Martinelli G; Rosti G; Baccarani M., Pancreatic enzymes elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure, «HAEMATOLOGICA», 2009, 94, pp. 1758 - 1761 [Articolo in rivista]
Testoni N; Marzocchi G; Luatti S; Amabile M; Baldazzi C; Stacchini M; Nanni M; Rege-Cambrin G; Giugliano E; Giussani U; Abruzzese E; Kerim S; Grimoldi MG; Gozzetti A; Crescenzi B; Carcassi C; Bernasconi P; Cuneo A; Albano F; Fugazza G; Zaccaria A; Martinelli G; Pane F; Rosti G; Baccarani M., Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response, a study of the GIMEMA CML WP., «BLOOD», 2009, 114(24), pp. 4939 - 4943 [Articolo in rivista]
Natale V.; Fabbri M.; Esposito M.J.; Martoni M.; Tonetti L.; Cicogna P., Cognitive performance during a night without sleep., in: Sleep deprivation: causes, effects and treatment, HAUPPAUGE, NY, Nova Science Publisher Inc., 2009, pp. 239 - 253 [Capitolo/Saggio in libro]